From Ajanta to Osaka: IGNCA Brings India’s Eternal Spirit to the Global Stage indiaeducationdiary.in...Read More[]
City List
- Ahmadnagar
- Ajanta
- Akluj
- Akola
- Alibagh
- Amarnath
- Amravati
- Aurangabad
- Badlapur
- Baramati
- Bhandara
- Bhayandar
- Bhiwandi
- Bhor
- Bhudgaon
- Bhusawal
- Bid
- Boisar
- Buldhana
- Chandrapur
- Chinchwad
- Chitegaon
- Dahanu
- Dhule
- Dombivli
- Elephanta
- Ellora
- Gadchiroli
- Gharapuri
- Gondia
- Hingoli
- Ichalkaranji
- Igatpuri
- Islampur
- Jaisingpur
- Jalgaon
- Jalna
- Kalva
- Kalyan
- Karad
- Karjat
- Kashid
- Kolhapur
- Kopargaon
- Kudal
- Latur
- Lonavale
- Mahabaleshwar
- Mahad
- Maharashtra
- Malegaon
- Malvan
- Manpada
- Matheran
- Mira Road
- Miraj
- Mumbai
- Mumbai Bombay
- Mumbra
- Murbad
- Murud
- Nagothana
- Nagpur
- Nanded
- Nandurbar
- Nashik
- Navi Mumbai
- Osmanabad
- Paldhi
- Palghar
- Panchgani
- Panvel
- Parbhani
- Pimpri Chinchwad
- Pune
- Raigad
- Ramtek
- Ratnagiri
- Sangamner
- Sangli
- Satara
- Shegaon
- Shirdi
- Sindhudurg
- Solapur
- Talegaon Dabhade
- Taloja
- Tarapur
- Thane
- Trimbakeshwar
- Ulhasnagar
- Vada
- Vasai
- Vengurla
- Wadgaon
- Waluj
- Wardha
- Washim
- Yavatmal
News from City Ajanta, State Maharashtra
Ajanta Pharma Consolidated March 2025 Net Sales at Rs 1,170.41 crore, up 11.04% Y-o-Y Moneycontrol...Read More[]
Buy Ajanta Pharma; Target Price Revised Jobaaj Stories...Read More[]
Ajanta Pharma shares fall 5% after Q4 results; should you buy, sell or hold? MSN...Read More[]
AJANTA PHARMA REVENUES GREW ~11 PERCENT YOY ICICI Direct...Read More[]
Ajanta Pharma shares fall 5% after Q4 results; should you buy, sell or hold? Business Today...Read More[]
Ajanta Pharma Q4 Review: Revenue Inline But Margins Contract- Systematix Maintains Buy, Cuts Target Price NDTV Profit...Read More[]
Ajanta Pharma Q4 Review: Revenue Inline But Margins Contract- Systematix Maintains 'Buy', Cuts Target Price NDTV Profit...Read More[]
Buy Ajanta Pharma; target of Rs 3180: Choice Equity Broking Moneycontrol...Read More[]
Ajanta Pharma consolidated net profit rises 11.12% in the March 2025 quarter Business Standard...Read More[]
Stock Recommendations Today: Varun Beverages, Ajanta Pharma, Bandhan Bank On Brokerages Radar NDTV Profit...Read More[]
Ajanta Pharma Full Year 2025 Earnings: Revenues Beat Expectations, EPS In Line simplywall.st...Read More[]
Ajanta Pharma re-appoints Madhusudan B Agrawal as Vice Chairman, Executive Director Medical Dialogues...Read More[]
Buy Ajanta Pharma; target of Rs 3260: Motilal Oswal Moneycontrol...Read More[]
Ajanta Pharma Q4 net up 11 pc at Rs 225 cr theweek.in...Read More[]
Ajanta Pharma Q4 Profit Rises 11% to ₹225 Crore India Infoline...Read More[]
Ajanta Pharma Q4 Results: Revenue, margins miss estimates as Africa business weighs CNBC TV18...Read More[]
Ajanta Pharma Reports Stable Financial Performance Amid Score Evaluation Shift in April 2025 MarketsMojo...Read More[]
Ajanta Pharma Ltd Share Price Today, AJANTPHARM Share Price NSE, BSE Business Today...Read More[]
Ajanta Pharma Shows Mixed Performance Amid Broader Market Decline and Long-Term Resilience MarketsMojo...Read More[]
Ajanta Pharma Adjusts Technical Outlook Amidst Stable Financial Performance and High Institutional Confidence MarketsMojo...Read More[]
Ajanta Pharma's Stock Reversal Highlights Resilience Amid Broader Market Decline MarketsMojo...Read More[]
Ajanta Pharma's Stock Reversal Highlights Resilience Amid Broader Market Decline MarketsMojo...Read More[]
Ajanta Soya's Evaluation Adjustment Highlights Strong Market Position and Financial Health MarketsMojo...Read More[]
Ajanta Pharma to Announce Q4 FY 2025 Financial Results TipRanks...Read More[]
Ajanta Pharma Limited (NSE:AJANTPHARM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? simplywall.st...Read More[]
Ajanta Pharma Limited (NSE:AJANTPHARM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? simplywall.st...Read More[]
Stock Recommendations Today: IndiGo, Ajanta Pharma, NTPC On Brokerages Radar NDTV Profit...Read More[]
Ajanta Pharma shares gain after Jefferies initiates coverage with 'Buy' call, sees 11% upside Moneycontrol...Read More[]
Ajanta Pharma Positioned For Steady Growth; Jefferies Initiates Coverage With Buy NDTV Profit...Read More[]
Ajanta Pharma to report strong profit growth till FY27, says Jefferies; check price target CNBC TV18...Read More[]
Ajanta Pharma shares gain after Jefferies initiates coverage with 'Buy' call, sees 11% upside Moneycontrol...Read More[]
3-member panel to probe boat mishap, company’s licence suspended Hindustan Times...Read More[]
Maharashtra Suspends Ajanta Catamaran License After Mandwa Mishap; 3-Member Probe Panel Formed Free Press Journal...Read More[]
Balancing Innovation and Inventory: The Ajanta Pharma Approach Logistics Insider...Read More[]
Balancing Innovation and Inventory: The Ajanta Pharma Approach Logistics Insider...Read More[]
Ajanta Pharma Shows Reversal Amid Broader Sector Gains, Yet Faces Long-Term Challenges MarketsMojo...Read More[]
Free entry to visitors at Ajanta-Ellora on April 18 lokmattimes.com...Read More[]
10 interesting facts about Maharashtra's Ajanta and Ellora Caves DNA India...Read More[]
Ajanta Pharma Faces Decline Amid Broader Sector Weakness and Trend Reversal MarketsMojo...Read More[]